# OXYBUTYNIN CHLORIDE
> **ANDA212798** · Abbreviated New Drug Application (Generic) · Sponsor: LEADING · Approved 2020-04-06
## Drug
- **FDA Application Number:** ANDA212798
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXYBUTYNIN CHLORIDE
- **Generic name:** OXYBUTYNIN CHLORIDE
- **Active ingredients:** OXYBUTYNIN CHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LEADING
- **Manufacturer:** Leading Pharma, LLC
- **First approval:** 2020-04-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212798)
---
*AI Analytics · CC0 1.0*